The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

Čájet eará veršuvnnaid (1)

Bibliográfalaš dieđut
Váldodahkki:	Barnes, E
Materiálatiipa:	Journal article
Almmustuhtton:	2002

Geahča maid

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection.
Dahkki: Barnes, E, et al.
Almmustuhtton: (2002)

Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection
Dahkki: Fleming, V, et al.
Almmustuhtton: (2010)

Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.
Dahkki: Fleming, V, et al.
Almmustuhtton: (2010)

Therapy of chronic hepatitis C virus infection in HIV co-infected people.
Dahkki: Fabris, P, et al.
Almmustuhtton: (2004)

Hepatitis C virus (HCV) cellular immune responses are induced during combination therapy but are not sustained.
Dahkki: Barnes, E, et al.
Almmustuhtton: (2000)

Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia
Dahkki: Muhammad Ayyub, et al.
Almmustuhtton: (2011-01-01)

Conservation within cytotoxic T lymphocyte epitopes in hepatitis C virus in chronic infection.
Dahkki: Christie, J, et al.
Almmustuhtton: (1997)

Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus
Dahkki: Samantha Therezinha Almeida Pereira Leite, et al.
Almmustuhtton: (2014-02-01)

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.
Dahkki: Lechner, F, et al.
Almmustuhtton: (2000)

Antiviral therapy in chronic hepatitis C virus infection
Dahkki: Irina Russu
Almmustuhtton: (2019-09-01)

Co-infection with hepatitis C virus and human T lymphocyte virus
Dahkki: Carlos Brites Alves

Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection
Almmustuhtton: (2009-09-01)

Immune responses against the hepatitis C virus and the outcome of therapy
Dahkki: Klenerman, P, et al.
Almmustuhtton: (2008)

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.
Dahkki: Brown, R, et al.
Almmustuhtton: (2005)

CD8(+) T lymphocyte (CD8(+)L) responses in acute and chronic hepatitis C virus (HCV) infection.
Dahkki: Christie, J, et al.
Almmustuhtton: (1998)

Response to hepatitis B virus vaccination in individuals with chronic hepatitis C virus infection.
Dahkki: Ashraf A Ashhab, et al.
Almmustuhtton: (2020-01-01)

Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection.
Dahkki: Barnes, E, et al.
Almmustuhtton: (2009)

Cellular Immune Responses during High-Dose Interferon-alpha Induction Therapy for Hepatitis C Virus Infection.
Dahkki: Barnes, E, et al.
Almmustuhtton: (2009)

The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
Dahkki: N D Yushchuk, et al.
Almmustuhtton: (2016-06-01)

Hepatitis B and Hepatitis C Viral Infections in Patients with Chronic Lymphocytic Leukemia
Dahkki: Gerald Y Minuk, et al.
Almmustuhtton: (2014-01-01)

Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System
Dahkki: Reda Biomy, et al.
Almmustuhtton: (2017-06-01)

The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection
Dahkki: Xianchun Meng, et al.
Almmustuhtton: (2016-04-01)

Dynamics of hepatitis C virus infection
Dahkki: Stefan Zeuzem, M.D., et al.
Almmustuhtton: (2002-04-01)

Predictive Role of Acute Phase Reactants in the Response to Therapy in Patients with Chronic Hepatitis C Virus Infection
Almmustuhtton: (2013-01-01)

Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus
Dahkki: K V Shmagel, et al.
Almmustuhtton: (2016-11-01)

T cell failure in hepatitis C virus infection.
Dahkki: Barnes, E, et al.
Almmustuhtton: (2002)

Chemokine antagonism in chronic hepatitis C virus infection.
Dahkki: Charles, E, et al.
Almmustuhtton: (2011)

Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection.
Dahkki: Ruian Ke, et al.
Almmustuhtton: (2015-06-01)

CD8+ lymphocyte (CD8+L) responses in acute hepatitis C virus (HCV) infection
Dahkki: Christie, J, et al.
Almmustuhtton: (1998)

The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
Dahkki: Jin Gu Kang, et al.
Almmustuhtton: (2023-05-01)

Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients
Dahkki: Camilla Rodrigues de Almeida Ribeiro, et al.
Almmustuhtton: (2021-01-01)

Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
Dahkki: Jae Young Oh, et al.
Almmustuhtton: (2019-07-01)

Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Dahkki: Ana Maria Ortega-Prieto, et al.
Almmustuhtton: (2017-09-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
Dahkki: V. P. Malyy, et al.
Almmustuhtton: (2020-05-01)

Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients.
Dahkki: Zhang, Y, et al.
Almmustuhtton: (2012)

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection.
Dahkki: Harcourt, G, et al.
Almmustuhtton: (2001)

THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
Dahkki: Sumit Dahal, et al.
Almmustuhtton: (2017-03-01)

Liver stiffness in chronic hepatitis C virus infection
Dahkki: Mihăilă Romeo-Gabriel
Almmustuhtton: (2019-06-01)

Glecaprevir and pibrentasvir combination therapy for hepatitis C virus-infected Japanese patients on hemodialysis
Dahkki: Yoshiaki Tanaka, et al.
Almmustuhtton: (2018-12-01)

Combination therapy for chronic hepatitis C: interferon and ribavirin.
Dahkki: Christie, J, et al.
Almmustuhtton: (1999)